IP Library Granted Patent US 8,501,975
Granted Patent B2
US 8,501,975 · App. 12/937,046 · Granted Aug 6, 2013

Method for manufacturing ruthenium carbene complexes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,501,975
App. No.
12/937,046
Granted
Aug 6, 2013
Kind
B2
Abstract

A method of manufacturing ruthenium carbene complexes and novel aryl alkylidene ruthenium complexes based on the method, the complexes able to used as catalysts in metathesis reactions.

Claims (53)

1. A process for preparing ruthenium complexes of the general formula (I)

RuX 2 (═CH—CH 2 R)L 2   (I),

wherein

X is an anionic ligand,

R is hydrogen or a (C 1 -C 18 )-alkyl, (C 3 -C 8 )-cycloalkyl, (C 2 -C 7 )-heterocycloalkyl, (C 6 -C 14 )-aryl or (C 3 -C 14 )-heteroaryl radical and

L is selected from the group consisting of phosphanes, phosphinites, phosphonites and phosphites,

which comprises

A) reacting an Ru metal salt of the general formula (II):

RuX x N y   (II),

wherein

x is an integer greater than or equal to 2 and

X is as defined above,

y is an integer greater than or equal to 0

and y>=1;

the ligands N are identical or different coordinating uncharged ligands;

with L in the presence of a base and a reducing agent and

B) subsequently reacting with a silylalkyne of the general formula III

R—C≡CSiR′ 3   (III),

wherein

R is as defined above,

the radicals R′ are identical or different radicals which can be selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl, (C 1 -C 8 )-alkoxy, (C 6 -C 10 )-aryloxy, (C 6 -C 10 )-aryl.

2. A process for preparing ruthenium complexes of the general formula

RuX 2 (═R 1 R 2 )L 2 ,

where

X is an anionic ligand,

L is selected from the group consisting of phosphanes, phosphinites, phosphonites and phosphites,

R 1 is hydrogen or a (C 1 -C 18 )-alkyl or (C 3 -C 8 )-cycloalkyl or (C 2 -C 7 )-heterocycloalkyl, (C 6 -C 14 )-aryl or (C 3 -C 14 )-heteroaryl radical and R 2 is a (C 6 -C 14 )-aryl or (C 3 -C 14 )-heteroaryl radical and the radicals R 1 and R 2 can have a 5-7-membered ring, which comprises

A) reacting an Ru metal salt of the general formula (II):

RuX x N y   (II),

wherein

x is an integer greater than or equal to 2 and

X is as defined above,

y is an integer greater than or equal to 0

and y>=1;

the ligands N are identical or different coordinating uncharged ligands;

with L in the presence of a base and a reducing agent and

B) subsequently reacting with a silylalkyne of the general formula III

R—C≡CSiR′ 3   (III),

wherein

R and R′ have the meanings given in claim 1 , and

C) subsequently reacting with an alkene of the general formula IV

H 2 C═CR′R 2   (IV),

wherein

R 1 and R 2 have the meanings given above.

3. The process according to claim 1 , wherein L is selected from the group consisting of triphenylphosphane, triisopropylphosphane, tricyclohexylphosphane and 9-cyclohexyl-9-phosphabicyclo[3.3.1]nonane.

4. The process according to claim 1 , wherein x=3 and y=0 for the Ru metal salt of the general formula RuX x N y and that the reduction of the Ru metal salt is carried out by means of hydrogen in the presence of metallic reducing agent.

5. The process according to claim 3 , wherein said reducing agent is magnesium.

6. The process according to claim 1 , wherein an excess of basic ligand is used as base.

7. The process according to claim 1 , wherein x>=2 and y>0 for the Ru metal salt of general formula RuX x N y and that the reduction of the Ru metal salt is carried out by means of alcohol or the formic acid-triethylamine complex.

8. The process according to claim 7 , wherein said reducing agent is a secondary alcohol.

9. The process according to claim 1 , wherein said base is an amine.

10. The process according to claim 9 , wherein said base is triethylamine or 1,8-diazobicyclo[5.4.0]undec-7-ene.

11. The process according to claim 2 , wherein L is selected from the group consisting of triphenylphosphane, triisopropylphosphane, tricyclohexylphosphane and 9-cyclohexyl-9-phosphabicyclo[3.3.1]nonane.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 3, 2024
From: EVONIK OPERATIONS GMBH FORMERLY KNOWN AS EVONIK DEGUSSA GMBH
To: UMICORE AG & CO. KG
Reel/Frame 068471/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2010
From: KADYROV, RENAT; ROSIAK, ANNA
To: EVONIK DEGUSSA GMBH
Reel/Frame 025231/0911 →